- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02218918
Comparison of Supervised Ground Walk Training and Treadmill Walk Training in COPD Patients (GWT/TWT)
Phase 0 Study of Comparison Between Ground Walk Training and Treadmill Walk Training in COPD Patients
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background: COPD is increasing mortality and morbidity globally. Pulmonary rehabilitation is a promising management in COPD management. Exercise training in form of aerobic (walking, cycling) and strength training is an important part of pulmonary rehabilitation. However access to traditional supervised exercise programs is questionable debate even in developed western countries. Unsupervised ground walk programs are often told by physicians but not properly prescribed.
Objective: To assess whether ground or treadmill walk is better in improving functional capacity and quality of life in COPD patients Design: Randomised controlled trial Procedure: Two arms 1) supervised ground walk training 2) supervised treadmill walk training. The intensity and progression of walk is based on 6 minute walk test. Quality of life will be gauged through Chronic respiratory questionnaire and functional capacity through 6 minute walk test.
Statistical analysis: Descriptive analysis for characterisation. Normality though Kolmogorov and Variables will be compared through paired and unpaired student t tests
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Tamilnadu
-
Coimbatore, Tamilnadu, India, 641004
- PSG Hospitals
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- stable COPD
- Stage II - IV
- Both genders
Exclusion Criteria:
- Cardiovascular diseases uncompensated
- uncompensated pleural diseases
- uncompensated liver diseases
- Recent surgeries less than 3 weeks
- malignancy receiving chemo and radiotherapy
- Recent exacerbations less than 3 months
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Supervised Treadmill Walk Training
Based on 6 minute walk distance, treadmill speed initiated and progression on basis new 6 minute walk distance every 2 weeks
|
3 times a week and 6 weeks
|
Experimental: Supervised Ground walk training
Ground walk training progressed on the basis of 6 minute walk distance (70 - 90%), Weekly 3 days and for 6 weeks
|
3 times a week and 6 weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Functional Capacity (6 MINUTE WALK TEST)
Time Frame: Baseline, 6 weeks
|
6 minute walk test according to standardisation of ATS
|
Baseline, 6 weeks
|
Quality of Life (Chronic Respiratory Questionnaire)
Time Frame: Baseline, 6 weeks
|
CRQ - interviewer based
|
Baseline, 6 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Baskaran Chandrasekaran, MPTh, Senior Physiotherapist
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PSG01Rehab
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Obstructive Pulmonary Disease (COPD)
-
University College, LondonUniversity of Cambridge; National Institute for Health Research, United Kingdom and other collaboratorsUnknownChronic Obstructive Pulmonary Disease (COPD).United Kingdom
-
Reham Mohammed ElmorshedyCompletedChronic Obstructive Pulmonary Disease(COPD)Egypt
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD).United Kingdom
-
Virginia Commonwealth UniversityFisher and Paykel HealthcareCompletedChronic Obstructive Pulmonary Disease(COPD)United States
-
Beaumont HospitalAerogenCompletedChronic Obstructive Pulmonary Disease | COPD | COPD Exacerbation | Copd Exacerbation AcuteIreland
-
Medtronic BRCUnknownCOPD | COPD Exacerbation
-
Chiesi Farmaceutici S.p.A.CompletedModerate to Severe Chronic Obstructive Pulmonary Disease (COPD)Bulgaria, Germany, Hungary, Poland, Russian Federation, United Kingdom
-
Chiesi Farmaceutici S.p.A.CompletedChronic Obstructive Pulmonary Disease (COPD) | COPDUnited Kingdom
-
Elpen Pharmaceutical Co. Inc.Completed
-
Aalborg UniversityCompletedChronic Obstructive Pulmonary Disease | COPD | COPD Exacerbation | COPD Exacerbation AcuteDenmark
Clinical Trials on Supervised Treadmill Walk training
-
European University Miguel de CervantesHospital Clínico Universitario de ValladolidCompletedPeripheral Arterial Disease | Intermittent ClaudicationSpain
-
University of Arkansas, FayettevilleRecruitingDiabetes Mellitus, Type 2United States
-
University of DelawareNational Institute of General Medical Sciences (NIGMS)RecruitingOsteoarthritis, KneeUnited States
-
Maastricht University Medical CenterUnknownPAOD (Peripheral Arterial Obstructive Disease)Netherlands
-
University of MinnesotaNot yet recruiting
-
Universiti Tunku Abdul RahmanCompleted
-
Riphah International UniversityRecruiting
-
Marquette UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruitingMultiple SclerosisUnited States
-
University of ManchesterUnknownCardiovascular Diseases | Peripheral Arterial Disease
-
Julius-Maximilians UniversityHannover Medical School; Goethe University; Triemli Hospital; Mukoviszidose eV... and other collaboratorsCompletedCystic FibrosisGermany, Switzerland